Characterization of CD4 + Cytotoxic Lymphocytes and Apoptosis Markers Induced by Trypanossoma cruzi Infection

Scandinavian Journal of Immunology

Volumn 76, Issue 3, 2012, Pages 311-319

  Keesen, T S L ^a   Gomes, J A S ^b,c   Fares, R C G ^c   de Araujo F F ^c   Ferreira, K S ^b   Chaves, A T ^c   Rocha, M O C ^b   Correa Oliveira, R ^c,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Institute of Science and Technology of Tropical Diseases   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD45RO ANTIGEN; FAS ANTIGEN; FAS LIGAND; GRANZYME B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EX VIVO STUDY; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GRANZYMES; HEART DISEASES; HUMANS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TRYPANOSOMA CRUZI;

EID: 84865386747     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02730.x     Document Type: Article

References (25)

1. Rocha MO, Teixeira MM, Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 2007;5:727-43.
2. Tarleton RL, Sun J, Zhang L, Postan M. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun 1994;62:1820-9.
3. Talvani A, Ribeiro CS, Aliberti JC et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2000;2:851-66.
4. + B cells or activated T cells of chagasic patients, respectively. Scand J Immunol 2000;51:91-7.
5. Dutra WO, Gollob KJ. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 2008;21:287-92.
6. + lymphocytes. Am J Trop Med Hyg 1993;48:637-44.
7. Fuenmayor C, Higuchi ML, Carrasco H et al. Acute Chagas' disease: immunohistochemical characteristics of T cell infiltrate and its relationship with T. cruzi parasitic antigens. Acta Cardiol 2005;60:33-7.
8. Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004;104:2840-8.
9. + T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2000;18:275-308.
10. Wilson NS, Dixit V, Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 2009;10:348-55.
11. +) CTLs ex vivo. J Immunol 2002;168:5954-8.
12. McElroy DS, Badstibner AM, D'Orazio SE. Use of the CD107 mobilization assay reveals that cytotoxic T lymphocytes with novel MHC-Ib restriction are activated during Listeria monocytogenes infection. J Immunol Methods 2007;328:45-52.
13. + T lymphocytes with cellular maturation. J Exp Med 2006;203:2865-77.
14. +)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. Eur J Immunol 2001;31:2512-20.
15. Stuller KA, Cush SS, Flano E. Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations. J Immunol 2010;184:3850-6.
16. +, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood 2004;103:2238-47.
17. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 2003;71:1185-93.
18. + and CD28- cells from chagasic patients: distinct repertoire and cytokine. Clin Exp Immunol 2004;137:129-38.
19. Costa RP, Gollob KJ, Fonseca LL et al. T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand J Immunol 2000;51:511-9.
20. Dutra WO, Rocha MO, Teixeira MM. The clinical immunology of human Chagas disease. Trends Parasitol 2005;21:581-7.
21. Guillermo LV, Silva EM, Ribeiro-Gomes FL et al. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J Leukoc Biol 2007;81:942-51.
22. Brown DM. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol 2010;262:89-95.
23. + CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. J Immunol 1996;156:153-9.
24. + cytotoxic T cells. Proc Natl Acad Sci USA 1994;91:4185-9.
25. +) T cells from patients with different clinical forms of Chagas' disease. Hum Pathol 2011;42:299-301.